COVID-19

News

AZ makes plans to supply 2 billion doses of COVID-19 vaccine

AstraZeneca has announced new plans to increase the global supply of Oxford University’s COVID-19 vaccine to more than two billion doses after striking agreements with several global not-fo

News

10 million on NHS waiting lists in COVID-19 second peak, acc...

Almost 10 million patients could be on waiting lists for NHS treatment by the end of the year amid the anticipated second peak of the COVID-19 outbreak, according to estimates from the make

Views & Analysis

Coronavirus pharma news roundup – 04/06/20

Are pharma's efforts to tackle coronavirus working? We highlight the top R&D, digital and market access news for COVID-19 from the past week.

News

Gilead's remdesivir could be $7.7bn blockbuster - analyst

An influential analyst has upped his previously cautious assessment of the sales potential of Gilead’s COVID-19 drug remdesivir, saying sales could reach $7.7 billion in 2022.

News

hydroxychloroquine sulphate tablets, in evaluation for treatment of COVID-19.Denmark, Mars 22, 2020

WHO restarts trial of COVID-19 drug hydroxychloroquine

The World Health Organization has restarted its trial of COVID-19 drug hydroxychloroquine, the malaria drug favoured by president Donald Trump, after a temporary halt because of safety conc

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Accelerating pharma's digital IQ as customer engagement evol...

The COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to engage with healthcare professionals (HCPs) and other stakeholders.

AZ makes plans to supply 2 billion doses of COVID-19 vaccine

10 million on NHS waiting lists in COVID-19 second peak, acc...

Coronavirus pharma news roundup – 04/06/20

Gilead's remdesivir could be $7.7bn blockbuster - analyst

WHO restarts trial of COVID-19 drug hydroxychloroquine

Accelerating pharma's digital IQ as customer engagement evol...

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

COVID-19

Editor's Picks